Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Apr 22;17(4):e0267509. doi: 10.1371/journal.pone.0267509

Functional exploration of the glycoside hydrolase family GH113

Marie Couturier 1,*, Mélanie Touvrey-Loiodice 1, Nicolas Terrapon 2, Elodie Drula 2,3, Laurine Buon 1, Christine Chirat 4, Bernard Henrissat 5,6, William Helbert 1
Editor: Israel Silman7
PMCID: PMC9032380  PMID: 35452491

Abstract

β-Mannans are a heterogeneous group of polysaccharides with a common main chain of β-1,4-linked mannopyranoside residues. The cleavage of β-mannan chains is catalyzed by glycoside hydrolases called β-mannanases. In the CAZy database, β-mannanases are grouped by sequence similarity in families GH5, GH26, GH113 and GH134. Family GH113 has been under-explored so far with six enzymes characterized, all from the Firmicutes phylum. We undertook the functional characterization of 14 enzymes from a selection of 31 covering the diversity of the family GH113. Our observations suggest that GH113 is a family with specificity towards mannans, with variations in the product profiles and modes of action. We were able to assign mannanase and mannosidase activities to four out of the five clades of the family, increasing by 200% the number of characterized GH113 members, and expanding the toolbox for fine-tuning of mannooligosaccharides.

Introduction

β-mannans (referred to as mannans throughout this manuscript) define a heterogeneous group of polysaccharides with a common main chain of β-1,4-linked mannopyranoside residues. Mannans are found in the cell wall of algae, in plant seeds and beans, and are a major component of wood hemicelluloses (e.g. galactoglucomannan) embedding the fibril architecture of the matrix [1, 2]. Semi-crystalline mannans participate in the structural architecture of cell walls devoid of cellulose fibrils such as the algae Porphyra sp. [3] or Acetabularia sp [46]. In crystalline mannan, the polysaccharide structure and packing of the chains are very similar to those of cellulose [7]. Mannans can also be extracted from beans or seeds giving gums appreciated in food industry (e.g. guar gum, tara gum, carob gum; [8]). In gums, mannan chains are decorated by carbohydrate components such as galactopyranoside residues in galactomannan gums, or by non-carbohydrate groups (e.g. acetate, sulfate) depending on the botanical origin of the macromolecules. Galactomannan seed gums are already exploited as stabilizer and thickener in the food and cosmetic industries [1, 8]. However, despite their abundance in plant cell wall mannans are under-exploited and their valorization would be key towards sustainable biorefineries. For example, glucomannans are a co-product of the pulp and paper industry, more especially when the process leads to the production of highly refined cellulose (e.g. nanocrystalline cellulose) which requires the extraction of hemicelluloses [9]. Potential applications of wood glucomannan as emulsifiers and stabilizers [10] or platform chemicals [11] have started to be evaluated. Recently, oligo-mannans were found to promote growth of some beneficial bacteria in animal and human gut microbiota, suggesting that these oligosaccharides could be used advantageously as ingredient in prebiotic formulation [1214]. These investigations revealed that the properties of the series of oligo-mannans were correlated to their size and their degree of substitution. As examples, a degree of polymerization of 2 to 3 (DP2/DP3) had a positive effect on the growth of Lactobacillus sp. [15] while DP3/DP4 were more favorable for the growth of Lactobacillus reuteri [16]. This example illustrates the need for fine-tuning of the oligo-mannan structures, which requires appropriate enzymes with well-defined recognition properties and mode of action.

The cleavage of β-linked mannopyranose residues is catalyzed by β-mannanases (EC 3.2.1.78) found in glycoside hydrolase families: GH5, GH26, GH113, and GH134 of the Carbohydrate-Active enzyme classification (CAZy, www.cazy.org [17]). GH134 β-mannanases adopt a three -dimensional structure similar to that of lysozyme [18] and cleave the glycosidic bond with an inversion of the anomeric configuration [19]. Contrasting with family GH134, the other families of mannan-degrading enzymes belong to same structural clan GH-A. Accordingly, mannanases from families GH5, GH26 and GH113 share remote homology, notably testified by the same (β/α)8 barrel three-dimensional structure, the same catalytic amino acids (Glu/Glu, catalytic nucleophile/catalytic proton donor) and the same catalytic mechanism leading to the retention of the anomeric configuration. GH5 and GH26 are longtime known families, from which numerous members have been characterized, whereas GH113 is a more recent, less studied family. The CAZy website (October 2021) listed for the GH113 family: 1,346 protein sequences from bacterial origin, six sequences from Archaea, four sequences from viruses and nine sequences from Eukaryotic origin, reflecting the bias in taxonomical sequencing. Among Archaea and Eukaryota encoding a GH113, most of the organisms seem to be from aquatic environment. To date, six GH113 enzymes have been biochemically characterized, namely from Alicyclobacillus acidocaldarius TC-12-31 [20], Alicyclobacillus sp. [21], Amphibacillus xylanus NBRC 15112 [22], Bacillus sp. N16-5 [23], Roseburia intestinalis L1-82 [24] and Faecalibacterium praunsnitzii SL3/3 (the latter was published during the course of this study [25]). All these enzymes degrade β-mannan polysaccharides and/or oligosaccharides: endo-β-mannanase activity has been identified for four of them (i.e. the enzymes cleave randomly the mannan backbone), and reducing-end exo-mannosidase activity was described for R. intestinalis and F. spraunitzii enzymes (i.e. the enzymes release mannose from the extremity of manno-oligosaccharides). The crystal structures of three GH113 enzymes have been solved, confirming their belonging to clan GH-A [2022]. Hence, the diversity of GH113 family remains little explored with few enzymes characterized with high sequence similarity (>54% identity on the catalytic domain sequences across enzymes).

In this context, we selected a set of 31 enzymes on the basis of protein sequence diversity, aiming at unveiling the functional diversity of the under-explored GH113 family.

Results

Bioinformatic analysis of the GH113 family

Analysis of the GH113-containing proteins revealed that the vast majority are composed of this sole domain, with a single exception in the marine bacterium Ardenticatena sp. whose GH113 bears a Carbohydrate Binding Module (CBM) from family CBM8. Binding to cellulose has been demonstrated for one CBM8 which shares only 36% identity with the CBM8 from Ardenticatena sp. Many other CBM8 sequences are found attached to a variety of enzymes, including GH18 enzymes which are mostly chitinases, or, interestingly, putative mannanases from the GH5_40 subfamily. Some sequences carry a C-terminal extension that careful analysis did not allow to relate to any known CBM or any other known module. Signal peptides were identified on approximately 54% of the sequences. A distance tree was built from the catalytic domain sequences of 511 enzymes belonging to GH113 family. This tree showed two large and three small clades driven mostly by the taxonomy (Figs 1 and S1). The large Clade 1 mainly encompasses sequences belonging to the Firmicutes phylum, including all enzymes characterized to date. Most of the sequences in Clade 1 are devoid of signal peptides (83%), suggesting an intra-cellular localization of the enzymes. The other clades are unexplored so far, without any characterized representatives. Clades 2, 3 and 4 are small clades gathering enzymes from various phyla: Clade 2 gathers mostly Alphaproteobacteria and Gammaproteobacteria, Clade 3 Actinobacteria and the few eukaryotic sequences, and Clade 4 other Alphaproteobacteria and a few diverse phyla including Archae. Signal peptides were predicted on 56% for Clade 2, 84% for Clade 3 and 57% for Clade 4. Finally, the large Clade 5 is dominated by Bacteroidetes species, including many strains isolated from marine environment. Signal peptides were frequently encountered in this clade (83%), suggesting an extracellular localization. The phylogenetic tree was used as a guide to select a panel of 31 enzymes, covering the diversity of the GH113 family, for biochemical investigation (Table 1 and Figs 1 and S1).

Fig 1. Phylogenetic tree of family GH113.

Fig 1

Enzymes studied here are shown with red symbols: filled dots indicate that an activity was assigned to the enzyme, empty ones indicate that no activity could be demonstrated. Stars indicate that the target protein was not obtained in a soluble form. Enzymes characterized in previous studies are labeled in grey. A high-resolution phylogenetic tree is available in Supplementary Material, S1 Fig.

Table 1. List of enzymes studied in this work, their characteristics and qualitative activities on mannan substrates.

Strains GenBank SigP Sol GlcM GalM M Oligo-M Mode of action
Clade 1
Opitutaceae bacterium TAV5 AHF90006.1 N - na na na na
Ruminococcus bicirculans CCO05952.1 N + + + + (M2) nd Endo
Clostridium cellulovorans 743B ADL53106.1 N + + + + (M2) nd Endo
Paenibacillus mucilaginosus 3016 AFC30869.1 N + + + + (M2) nd Endo
Paenibacillus mucilaginosus 3016 AFC29300.1 N + + + + (M2) nd Endo
Paenibacillus stellifer AIQ63165.1 N + - - - + (M2+M1) Exo
Paenibacillus sp. FSL R7-0273 AIQ46016.1 N + - - - + (M2+M1) Exo
Carnobacterium sp. WN1359 AGY82530.1 N + - - - + (M2+M1) Exo
Lactococcus lactis subsp. Lactis AJA57161.1 N + - - - -
Faecalibacterium prausnitzii M21/2 EDP22100.1 N + - - (+) + (M2+M1) Exo
Coprococcus sp. ART55/1 CBK82649.1 N + + + + nd Endo
Clostridium saccharoperbutylacetonicum N1-4(HMT) AGF59019.1 N + - - - + (M2+M1) Exo
Alicyclobacillus acidocaldarius TC-12-31 (AaMan113A)* ABG77968.1 Endo*
Alicyclobacillus sp. (Man113A)* AGN12833.1 Endo*
Amphibacillus xylanus NBRC 15112 (AxMan113A)* BAM48369.1 Endo*
Bacillus sp. N16-5 (Man113A)* AML27062.1 Endo*
Faecalibacterium prausnitzii SL3/3 CBL01979.1 Exo*
Roseburia intestinalis L1-82 (RiGH113)* VCV21219.1 Exo*
Clade 2
Phenylobacterium zucineum HLK1 ACG77425.1 N + - - - -
Xanthomonas campestris str. ATCC 33913 AAM39996.1 Y + + + + (M3+M4) nd Endo
Xanthomonas citri subsp. citri AJZ27962.1 Y + + + + (M3+M4) nd Endo
Clade 3
Candidatus Acetothermus autotrophicum BAL60159.1 N + - - + (M3+M4) nd Endo
Streptomyces davawensis JCM 4913 CCK30803.1 N + - - - -
Tetrahymena thermophila SB210 EAR94190.1 Y - na na na na
Halobacteriovorax marinus SJ CBW26415.1 N - na na na na
Clade 4
Candidatus Korarchaeum cryptofilum OPF8 ACB07175.1 Y + + + + (M3+M4) nd Endo
uncultured Acetothermia bacterium BAL57546.1 Y + - - - -
Clade 5
Salinibacter ruber DSM 13855 ABC45350.1 N - na na na na
Hymenobacter sp. DG5B ALW87438.1 N + - - - -
Gramella sp. MAR_2010_102 SDR82740.1 N - na na na na
uncultured Flavobacteriia bacterium CCG00503.1 Y + - - - -
Maribacter sp. HTCC2170 EAR00501.1 Y + - - - -
Dokdonia sp. MED134 EAQ39091.1 Y + - - - -
Flavobacteria bacterium BBFL7 EAS20280.1 Y + - - - -
Polaribacter vadi AOW18367.1 Y + - - - -
Formosa agariphila KMM 3901 CDF78977.1 Y + - - - -
Fibrella aestuarina BUZ 2 CCH01584.1 N - na na na na

Main end-products are given into brackets for linear polysaccharides. SigP: Signal peptide (Y for predicted; N otherwise). Sol: Expression of soluble proteins. Substrates: + for degradation of the substrate; (+) for a weak degradation and—for no degradation. nd: not detected. na: not applicable

*: results from previous works. Underlined GenBank accession numbers highlight sequences for which the 3D structure was solved.

(GlcM: Glucomannan, M: β (1,4) mannan, GalM: galactomannan, OligoM: Oligo-mannans).

Production of GH113 β-1,4 mannanases and substrate specificity

For this study, codon optimization for heterologous expression in E. coli, gene synthesis and cloning of the 31 targets were outsourced (Nzytech, Portugal). Signal peptides and other extensions were trimmed in order to conserve only the predicted catalytic domain. Twenty-five targets (81%) were successfully overexpressed in E. coli BL21(DE3) and soluble. The remaining six proteins were produced as insoluble inclusion body, notably the eukaryotic GH113 from Tetrahymena thermophila and an enzyme from the extremely halophilic bacterium Salinibacter ruber. The purity of enzymes was attested by a single band visible on SDS-PAGE and estimated to be >90%. The molecular weights were ranging from 35 kDa to 47 kDa, as expected. Final protein concentrations were between approximately 2 and 6 mg.mL-1. All the enzymes were produced and screened at least twice to demonstrate reproducibility.

At first, the purified proteins were screened for activity on a set of various substrates, including several mannan polysaccharides from different biological origins (e.g. β-1,4-mannan, glucomannan, galactomannan) (S2 Fig), manno-oligosaccharides and pNP-β-mannopyranoside (S1 and S2 Tables). Out of the 25 soluble enzymes, 14 were found to be active on at least one mannan or manno-oligosaccharide substrate. Active enzymes were identified in all Clades but Clade 5, where no member showed even a weak activity. The seven Bacteroides proteins of Clade 5 as well as proteins from other clades for which no activity had been detected on the first set of substrates were subjected to a second screening round on a complementary set of substrates (S2 Table). Despite the diversity of polysaccharides, oligosaccharides and synthetic substrates tested, no activity was observed for any of the proteins, including all the proteins from Clade 5. Qualitative assessment of the degradation capability of the various mannans and manno-oligosaccharides by enzymes from Clades 1 to 4 is given in Table 1.

Analysis of the mode of action for GH113 β-mannanases on debranched beta -1,4 mannan

End-products and mode of action of the enzymes were determined by size-exclusion chromatography. Endo-acting enzymes cleave the polymeric substrate into a range of oligosaccharides whose sizes decrease as the degradation proceeds. Accordingly, five enzymes of Clade 1 revealed an endo-mode of action on linear beta-1,4 mannan (Fig 2). Five other enzymes exhibited activity on a mix of linear manno-oligosaccharides, whereas no significant activity was measured on polysaccharides or on pNP-β-mannopyranoside. This is exemplified with EDP22100 (S3 Fig), which accumulated M2 and M1 after extended incubation with oligosaccharides. The activity of EDP22100 was further examined by HPAEC-PAD (Fig 3A) confirming the release of mannose from mannohexaose (M6). Intermediate products were detected in the shorter incubation times and quickly degraded. This analysis confirmed the exo-mannosidase activity that was also described in another F. prausnitzii strain during the course of our study [25]. To elucidate whether they were mannobiosidases or mannosidases, the four other enzymes with activity on oligosaccharides were similarly subjected to HPAEC-PAD analysis (Fig 3B). All of them were able to release mannose from M6, confirming that they are also exo-mannosidases.

Fig 2. Analysis of the endo mode of action of two GH113 representatives.

Fig 2

The degradation of debranched β 1,4 mannan by A: CCO05952 (Clade 1) and B: AJZ27962 (Clade 2) was monitored using size-exclusion chromatography. M2: mannobiose, M3: mannotriose, M4: mannotetraose.

Fig 3. Analysis of the exo mode of action of five GH113 Clade 1 representatives.

Fig 3

A: The degradation of mannohexaose (M6) by EDP22100 was monitored by HPAEC-PAD. B: Analysis of end-products released by AGY82530, AGF59019, AIQ46016 and AIQ63165 after overnight incubation with M6. M1: Mannose, M2: mannobiose, M3: mannotriose, M6: mannohexaose.

Clade 1 endo-acting enzymes were active on all tested mannans (e.g. glucomannan, galactomannan, beta-1,4-mannan) and released mostly mannobiose (M2) and mannotriose (M3) as main end-products as shown with CCO05952 in Fig 3A. Four enzymes from Clades 2, 3 and 4 were also found to be active on β-mannan polysaccharides. Degradation kinetics monitored by chromatography revealed they were all endo-acting enzymes, releasing a range of oligosaccharides over the course of the reaction. mannotriose (M3) and mannotetraose (M4) were the main end products, as illustrated with the enzyme AJZ27962 on linear mannan (Fig 3B). No transglycosylation activity was observed with any of the tested enzymes in our experimental conditions. Specific activities were determined for one representative from Clades 1 and 2, CCO05952 and AJZ27962, respectively, showing that Clade 1 CCO05952 exhibits a similar activity on various mannans, whereas Clade 2 AJZ27962 has highest activity on glucomannan and decreasing activity with increasing galactose substitutions (Table 2).

Table 2. Specific activity of representatives of M1+ M2 producing enzymes (AJZ27962.1, Clade 1) and M3+M4 producing enzymes (CCO05952.1, Clade 2) towards mannans.

Specific activity (U/mg)
AJZ27962.1 CCO05952.1
Konjac glucomannan (0% Gal, mannose:glucose = 60:40) 9.39 +/-0.51 3.00 +/-0.30
Carob linear β-1,4 mannan (0% Gal) 4.73 +/-0.64 3.35 +/-0.0
Carob galactomannan (22% Gal) 4.14 +/-0.45 3.04 +/-0.0
Guar gum (50% Gal) 0.89 +/-0.34 2.79 +/-0.59

Discussion

Substrate specificity in the GH113 family

Activity on β-1,4-linked mannose-containing substrates was demonstrated for enzymes grouped in Clades 1 to 4 of the GH113 family. The specificity and the mode of action of these enzymes were carefully determined using a variety of mannan substrates. These analyses revealed different degradation profiles correlated to the mode of action and probably to the active site topology of the enzymes. Five enzymes of Clade 1 were found to be endo-acting enzymes producing mainly M2 and M3 end-products similarly to most of the other previously characterized enzymes grouped in this Clade [2023]. Five enzymes of Clade 1 had exo-mannosidase activity on oligomannans. All the enzymes grouped in Clade 1 were inactive against pNP-β-mannopyranoside, suggesting that productive binding requires at least two sub-sites. Inspection of sequence alignment showed that amino acids involved in the catalytic machinery and interaction with the substrates deduced from crystallographic studies [21, 22] are well conserved in this clade (S4 Fig). In addition, it did not reveal significant differences between endo- and exo-acting enzymes such as, for example, additional loop that could modify the active site topology or absence of specific amino acids that could be involved specially in substrate interactions. This probably explains that exo- and endo-acting enzymes do not group as independent branches in the phylogenetic tree.

To the best of our knowledge, no member of other Clades than the Firmicutes Clade 1 had been studied before the present work. Four out of the seven enzymes selected here among Clades 2, 3 and 4 have been identified as endo-acting mannanases. They show catalytic characteristics different from what is observed for Clade 1. Notably, all of the active enzymes from these three clades exhibit a mode of action leading to the production of longer oligosaccharides than enzymes from Clade 1, mannotriose (M3) and mannotetraose (M4) being the main end-products. One can hypothesize that the active site should be able to accommodate longer substrates and probably presents additional sub-sites to those described in crystallographic studies of Clade 1 mannanases. Accordingly, we notice that enzymes grouped in Clade 1 are generally devoid of signal peptide, whereas enzymes of Clades 2, 3 and 4 more frequently encode one. Therefore, one can hypothesize that the former are in charge of processing internalized mannan oligomers, whereas the latter might target longer polysaccharides outside of the cell. Accordingly, the studies of R. intestinalis Ri113A [24] and Bacillus sp. N16-5 [23] revealed that the GH113-encoding genes were co-localized in the genomes with genes encoding other enzymes involved in the breakdown of glucomannan, galactomannan and galactoglucomannan. Among these enzymes, endo-acting mannanases classified in GH5 or GH26 were identified as the first degraders of the polysaccharide chains. However, this is not supported by an analysis of CAZyme content for Clade 1 species, which revealed that a majority of these species do not encode any other mannan-degrading enzyme from known CAZy family (S5 Fig).

GH113 of unknown function

Beyond the assignment of mannanase and mannobiosidase activities of Clades 1 to 4, we were not able to identify the specific substrate of selected enzymes grouped in the large Clade 5. Sequence alignments showed that amino acids involved in the substrate recognition as well as those required for the catalytic machinery are well conserved (S4 Fig). Although disappointing, our observations confirm the importance of biochemical characterization to ascribe function of putative enzymes grouped in CAZy families. Challenging bioinformatics predictions with experimental data allows refining annotation methods and highlights the limitations of functional prediction and the attribution of a target substrate. Clade 5 mainly groups enzymes found in Bacteroidetes species living in marine environment. Therefore, the preferred substrate of these enzymes could be a poly- or oligosaccharide occurring in a marine organism but absent of our collection of substrates. This illustrates that functional characterization of CAZymes is often limited by the availability of substrates. Bacteroidetes species are known for displaying a large arsenal of Polysaccharide Utilization Loci (PUL, http://www.cazy.org/PULDB/, [26]), genomic organizations where genes encoding all the activities leading to the complete degradation of a specific polysaccharide (import, cleavage, regulation) are co-localized and co-regulated. Therefore, the occurrence of a gene in a PUL may help to infer its functional role in the catabolism pathway. In the case of the Bacteroidetes GH113 (Clade 5) there is a small number of genes predicted in a PUL compared to the size of the family (26/661, 4%). Moreover, these PULs contain none or a single additional degradative CAZyme (only three Cyclobacterium species having two GH144-encoding genes, usually involved in β-1,2 glucan breakdown). This suggests that these enzymes are unlikely to participate in a complex polysaccharide uptake. They might instead be used for the construction and/or remodeling of biofilm or an energy storage polysaccharide in these bacteria, as suggested by their presence on the genome close to Glycosyltransferase (GT) genes of family GT2, encoding enzymes involved in polysaccharide synthesis. Accordingly, we observed that among the large diversity of specificities in family GT2, some of the GT2 located in GH113-containing PULs exhibit similarity with mannosyltransferases.

Conclusion

The rational exploration of the diversity of GH113 family revealed that this family is probably a family targeting specifically mannans. The phylogenetic analysis suggested that all six members characterized so far belong to a unique clade mostly restricted to the Firmicutes phylum for which we further characterized six additional members. We further investigated three other clades without characterized members so far, that cover a broader taxonomic diversity, and we demonstrated the mannanase activity of GH113 from two Proteobacteria, an unclassified Bacteria and an Archeae. In a large fifth clade, specific of the Bacteroidetes phylum, despite the conservation of key amino acids, we were unable to ascribe a function to these proteins or even confirm that they are glycoside hydrolases.

This study increases by 200% the number of characterized GH113 and, interestingly, we observed different modes of action (e.g. endo-/exo) and various modalities of substrate recognition leading to different end-products. The set of enzymes studied herein complete the enzymes toolbox for the preparation of series oligo-mannans that may find some application, for example to produce prebiotics.

Materials and methods

Bioinformatics analyses and sequence selection

Protein accessions of non-fragmentary GH113 enzymes were extracted from the CAZy database (May 2021) and used to retrieve the corresponding amino-acid sequences from the NCBI database. The amino acid sequences were trimmed to isolate the GH113 catalytic domain. To reduce the initial set of 1319 sequences, we performed a CD-HIT [27] with a sequence identity threshold of 95%. The resulting 511 sequences were aligned using MAFFT tool (version 7.453, [28]) following the accuracy-oriented method with the option maxiterate of 1000. TrimAl v1.2 [29] was used to automatically remove poorly aligned regions from the alignment with the automated option. The alignment was used to compute a distance matrix based on maximum likelihood distances [30]. The resulting matrix distance was then used to construct a phylogenetic tree using FastME [31]. Peptide signals were predicted using Phobius [32].

Synthesis of GH113 encoding genes

The selected GH113 sequences are listed in Table 1. After removal of the signal peptide sequence when present and codon optimization for expression in Escherichia coli, the sequences were synthesized and inserted in pHTP1 expression vector in frame with a (His)6-tag located at the N-terminal end of the proteins (NZyTech, Portugal).

Heterologous expression and purification of recombinant GH113

Approximately 20 ng of each plasmid were used to transform E. coli BL21(DE3) competent cells. Resulting clones harboring the recombinant expression plasmids were grown in 5 ml LB precultures supplemented with 30 μg/mL kanamycin in a shaking incubator at 180 rpm and 37°C overnight. Cultures were subsequently carried out in 50 ml of NZY auto-induction LB media (NZYtech) medium supplemented with 30 μg/mL kanamycin, with 1/100 v/v overnight precultures and further incubated at 25°C for 30 hrs. Cultures were stopped by centrifugation at 4000g for 5 min. The bacterial pellet was resuspended in buffer A (50 mm Tris pH7.8, 300 mM NaCl, 10 mM Imidazole) with 50 μg/ml lysozyme and stored at -80°C overnight. After thawing, resuspended cells were incubated with DNAse at 10°C for 15 min. Insoluble fractions were removed by centrifugation at 40,000g for 30 min at 4°C. The proteins were purified by affinity chromatography using a nickel agarose affinity resin (Ni-NTA resin, Qiagen) loaded on poly-prep® chromatography columns (Bio-Rad), as described in [33]. The resin was equilibrated with buffer A and the His6-tagged recombinant enzymes were eluted with buffer A containing 300 mM imidazole. The purity of the fractions was estimated by 10% SDS-PAGE analysis. Before biochemical characterization, selected proteins were further purified on a gel permeation ENRich650 column (Bio-Rad) and eluted in 20 mM Tris-HCl pH 7.8, 100 mM NaCl. The purity of the fractions was assessed using 10% SDS-PAGE analysis.

Enzyme activity screening

Synthetic substrate assay

The list of p-nitrophenyl substrates (Sigma Aldrich) used in this study is given in S2 Table. Activities toward 5 mM pNP substrates were determined by measuring the release of 4-nitrophenol in 100 mM Tris HCl pH 7.8, NaCl 50 mM, using a 200-μl reaction volume and suitably diluted enzymes. Reactions mixtures were incubated at room temperature for 2 to 16 hrs and the release of 4-nitrophenol was quantified at 405 nm.

Polysaccharide assay

Polysaccharide originating from plant cell wall, seeds, animal and marine environment, were screened. The list of polysaccharide substrates tested in this study is available in S1 Table. Substrates were prepared as 0.4% solutions or suspensions in the case of insoluble substrates (i.e. ivory nut mannan, carob debranched mannan). To identify GH113 enzyme substrates, 200 μl reactions containing 0.2% substrate and suitably diluted enzyme (0.4–10.9 μM per assay) in 100 mM Tris HCl pH7.8, 50 mM NaCl were incubated in 10 kDa-microfiltration plates (10 kDa, PES, Pall corporation) for 16 hrs at 25°C under shaking. The reaction was terminated by filtration of reaction mixtures on a multiscreen HTS vacuum manifold (MSVMHTS00, Millipore) connected to a high-output vacuum pressure pump (Millipore). The filtrates were then analyzed by assaying reducing sugars using the ferricyanide assay [34] as described before [35].

Oligosaccharide assay

Oligosaccharides were prepared in-house from linear β-1,4 mannan. Ten milliliters of 0.4% mannan suspension were incubated with 100 μg of GH113 (AJZ27962.1) in Tris HCl 100 mM pH 7.8, NaCl 50 mM for 30 hrs at 25°C. The reaction was terminated by boiling for 10 min. After filtration on a 0.22 μm PES membrane, the obtained oligosaccharides were stored at -20°C until use. GH113 activities toward oligosaccharides were determined as follows: 100 μl of oligosaccharide solution were incubated with suitably diluted enzymes in Tris HCl 100 mM pH7.8, 50 mM NaCl and incubated for 16 hrs at 25°C under shaking, as described previously. The reactions were terminated by boiling for 5 min and products were analyzed as described in the next section. For M6 degradation experiments, 100μM M6 were incubated with the suitably diluted enzymes in 10 mM phosphate buffer pH 7.5 at 25°C under shaking and the reaction was terminated by boiling for 10 min and filtered on 10 kDa cut-off PES membranes.

Gel permeation chromatography

Enzymatic degradation of polysaccharides and oligosaccharides was validated by gel permeation chromatography using a Superdex peptide 10/300 (GE Healthcare) column connected to a high-performance liquid chromatography (HPLC) Ultimate 3000 system (Thermo Fisher). Injection volume was 50 μL and the elution was performed at 0.5 ml.min-1 in 0.1 M NaCl. Oligosaccharides were detected by differential refractometry (Iota 2 differential refractive index detector, Precision Instruments). Mannose and mannooligosaccharides ranging from DP2 to DP4 were used as standards.

HPAEC-PAD

Enzymatic degradation of M6 was followed using high-performance anion-exchange chromatography with pulsed amperometric detection on a Dionex ICS-6000 system. Hydrolysis products were loaded onto a CarboPac PA100 2 x 250 mm column coupled to a CarboPac PA100 2 x 50 mm guard column. Injection volume was 5 μl and flow rate was 0.25 ml/min. Elution was carried out from 0 to 15 min in NaOH 0.1 M with a gradient from 0 to 0.5 M sodium acetate. The elution was followed by cleaning and regeneration of the column with 10 min of NaOH 0.2 M and 1M sodium acetate, 10 min NaOH 0.2M and 10 min NaOH 0.1 M.

Supporting information

S1 Fig. High resolution phylogenetic tree of family GH113.

Major taxonomic groups were color-coded (tree branches and leaf labels): red for Firmicutes, blue for Alphaproteobacteria, green for Gammaproteobacteria, black for Actinobacteria and brown for Bacteroidetes.

(PNG)

S2 Fig. Characteristics of the mannans used in this study.

Symbolic representation of glycans is given with blue dots: glucose, green dots: mannose, yellow dots: galactose.

(DOCX)

S3 Fig. Degradation of linear mannooligosaccharides by a clade 1 GH113 representative.

The degradation of manno-oligosaccharides by EDP22100 was monitored using size-exclusion chromatography. M1: Mannose, M2: Mannobiose, M3: mannotriose, M4: mannotetraose.

(DOCX)

S4 Fig. Multiple alignment of selected GH113 sequences.

Conserved amino acids are highlighted with a red background, catalytic amino acids are indicated by a grey dot. Multiple alignment was generated using the MEGA Software (Tamura et al., 2021) and the figure was edited using ESPript 3 (Robert and Gouet, 2014).

Supplementary references

Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol. 2021;38:3022–3027. doi: 10.1093/molbev/msab120.

Robert X, Gouet P. Deciphering key features in protein structures with the new ENDscript server. Nucl Acids Res. 2014; 42(W1): W320-W324. doi: 10.1093/nar/gku316).

(DOCX)

S5 Fig. Comparison of mannanase-encoding gene repertoires in Clade 1 organisms using double hierarchical clustering.

Top tree shows mannanase families or subfamilies, left tree highlights clusters in Clade 1 fungi defined by number of mannanase-encoding genes. Abundance of the different genes within a family is represented by a colour scale from 0 (white) to the maximal number for each family (red) per species. The figure was edited using Morpheus (https://software.broadinstitute.org/morpheus/). A hierarchical clustering was performed with the option "one minus pearson correlation " on the rows. The linkage method used was average.

(DOCX)

S1 Table. List of polysaccharides used in this study.

CM: Carboxymethyl, CWP: Cell wall polysaccharides.

(DOCX)

S2 Table. List of synthetic substrates used in this study.

(DOCX)

Acknowledgments

Sophie Mathieu and Laurent Poulet are thanked for their help with plasmid transformation.

Abbreviations

CAZymes

Carbohydrate-Active enZymes

DP

degree of polymerization

GH

Glycoside Hydrolase

HPAEC-PAD

High-performance anion-exchange chromatography with pulsed amperometric detection

M1

Mannose

M2

mannobiose

M3

mannotriose

M4

mannotetraose

M6

Mannohexaose

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was financially supported by the Institut Carnot PolyNat (ANR-17-CARN-0025-0). Support was received from the Glyco@Alps Cross-Disciplinary Program (Grant ANR-15-IDEX-02), Labex ARCANE (Grant ANR-11-LABX-0003), and Grenoble Graduate School in Chemistry, Biology, and Health (Grant ANR-17-EURE-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Rodriguez-Gacio MDC, Iglesias-Fernandez R, Carbonero P, Matilla AJ. Softening-up mannan-rich cell walls. J Exp Bot. 2012;63: 3976–3988. doi: 10.1093/jxb/ers096 [DOI] [PubMed] [Google Scholar]
  • 2.Terrett OM, Lyczakowski JJ, Yu L, Iuga D, Franks WT, Brown SP, et al. Molecular architecture of softwood revealed by solid-state NMR. Nat Commun. 2020;11: 5773. doi: 10.1038/s41467-020-19585-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Frei E, Preston RD. Non-cellulosic structural polysaccharides in algal cell walls—II. association of xylan and mannan in Porphyra umbilicalis. Proc R Soc Lond B Biol Sci. 1964;160: 314–327. doi: 10.1098/rspb.1964.0042 [DOI] [PubMed] [Google Scholar]
  • 4.Frei E, Preston RD. Non-cellulosic structural polysaccharides in algal cell walls—III. Mannan in siphoneous green algae. Proc R Soc Lond B Biol Sci. 1968;169: 127–145. doi: 10.1098/rspb.1968.0001 [DOI] [PubMed] [Google Scholar]
  • 5.Chanzy H, Grosrenaud A, Vuong R, Mackie W. The crystalline polymorphism of mannan in plant cell walls and after recrystallisation. Planta. 1984;161: 320–329. doi: 10.1007/BF00398722 [DOI] [PubMed] [Google Scholar]
  • 6.Dunn EK, Shoue DA, Huang XM, Kline RE, MacKay AL, Carpita NC, et al. Spectroscopic and biochemical analysis of regions of the cell wall of the unicellular ’mannan weed’, Acetabularia acetabulum. Plant Cell Physiol. 2007;48: 122–133. doi: 10.1093/pcp/pcl053 [DOI] [PubMed] [Google Scholar]
  • 7.Chanzy H, Perez S, Miller DP, Paradossi G, Winter WT. An electron diffraction study of the mannan I crystal and molecular structure. Macromolecules. 1987;20: 2407–2413. doi: 10.1021/ma00176a014 [DOI] [Google Scholar]
  • 8.Dierckx S, Dewettinck K. Seed Gums. In: Vandamme E, De Baets S, Steinbüchel A, editors. Biopolymers Vol 6 polysaccharides II: polysaccharides of eukaryotes. Berlin, Wiley VCH; 2002. pp. 321–344. [Google Scholar]
  • 9.Rajan K, Djioleu A, Kandhola G, Labbe N, Sakon J, Carrier DJ, et al. Investigating the effects of hemicellulose pre-extraction on the production and characterization of loblolly pine nanocellulose. Cellulose. 2020;27: 3693–3706. [Google Scholar]
  • 10.Valoppi F, Lahtinen M, Bhattarai M, Kirjoranta SJ, Juntti VK, Peltonen L, et al. KS. Centrifugal fractionation of softwood extracts improves biorefinery workflow and yields functional emulsifiers. Green Chem. 2019;21: 4691–4705. doi: 10.1039/C9GC02007A [DOI] [Google Scholar]
  • 11.López M, Vila C, Santos V, Parajó JC. Polymers manufacture of platform chemicals from pine wood polysaccharides in media containing acidic ionic liquids. Polymers (Basel). 2020;12(6): 1215. doi: 10.3390/polym12061215 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.La Rosa SL, Kachrimanidou V, Buffetto F, Pope PB, Pudlo NA, Martens EC, et al. Wood-derived dietary fibers promote beneficial human gut microbiota. mSphere. 2019;4: e00554–18. doi: 10.1128/mSphere.00554-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Michalak L, Gaby JC, Lagos L, La Rosa SL, Hvidsten TR, Tetard-Jones C, et al. Microbiota-directed fibre activates both targeted and secondary metabolic shifts in the distal gut. Nat Commun. 2020;11: 5773. doi: 10.1038/s41467-020-19585-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Deloule V, Boisset C, Hannani D, Suau A, Le Gouellec A, Chroboczek J, et al. Prebiotic role of softwood hemicellulose in healthy mice model. J Funct Foods. 2020;64: 103688. doi: 10.1016/j.jff.2019.103688 [DOI] [Google Scholar]
  • 15.Mary PR, Prashanth KVH, Vasu P, Kapoor M. Structural diversity and prebiotic potential of short chain β-manno-oligosaccharides generated from guar gum by endo-β-mannanase (ManB-1601). Carbohyd Res. 2019;486: 107822. doi: 10.1016/j.carres.2019.107822 [DOI] [PubMed] [Google Scholar]
  • 16.Kalidas NR, Saminathan M, Ismail IS, Abas F, Maity P, Islam SS, et al. Structural characterization and evaluation of prebiotic activity of oil palm kernel cake mannan oligosaccharides. Food Chem. 2017; 234: 348–355. doi: 10.1016/j.foodchem.2017.04.159 [DOI] [PubMed] [Google Scholar]
  • 17.Drula E, Garron ML, Dogan S, Lombard V, Henrissat B, Terrapon N. The carbohydrate-active enzyme database: functions and literature. Nucleic Acids Res. 2022;50(D1): D571–7. doi: 10.1093/nar/gkab1045 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Jin Y, Petricevic M, John A, Raich L, Jenkins H, Portela De Souza L, et al. A β-mannanase with a lysozyme-like fold and a novel molecular catalytic mechanism. ACS Cent Sci. 2016;2: 896–903. doi: 10.1021/acscentsci.6b00232 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Shimizu M, Kaneko Y, Ishihara S, Mochizuki M, Sakai K, Yamada M, et al. Novel β-1,4-mannanase belonging to a new glycoside hydrolase family in Aspergillus nidulans. J Biol Chem. 2015;290: 27914–27927. doi: 10.1074/jbc.M115.661645 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Zhang Y, Ju J, Peng H, Gao F, Zhou C, Zeng Y, et al. Biochemical and structural characterization of the intracellular mannanase AaManA of Alicyclobacillus acidocaldarius reveals a novel glycoside hydrolase family belonging to clan GH-A. J Biol Chem. 2008; 283: 31551–31558. doi: 10.1074/jbc.M803409200 [DOI] [PubMed] [Google Scholar]
  • 21.Xia W, Lu H, Xia M, Cui Y, Bai Y, Qian L, et al. A novel glycoside hydrolase family 113 endo-β-1,4-mannanase from Alicyclobacillus sp. strain A4 and insight into the substrate recognition and catalytic mechanism of this family. Appl Environ Microbiol. 2016;82: 2718–2727. doi: 10.1128/AEM.04071-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.You X, Qin Z, Yan Q, Yang S, Li Y1, Jiang Z. Structural insights into the catalytic mechanism of a novel glycoside hydrolase family 113 β-1,4-mannanase from Amphibacillus xylanus. J Biol Chem. 2018;293(30):11746–11757. doi: 10.1074/jbc.RA118.002363 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Song Y, Sun W, Fan Y, Xue Y, Liu D, Ma C, et al. Galactomannan degrading enzymes from the mannan utilization gene clade of alkaliphilic Bacillus sp. N16-5 and their synergy on galactomannan degradation. J Agric Food Chem. 2018;66: 11055–11063. doi: 10.1021/acs.jafc.8b03878 [DOI] [PubMed] [Google Scholar]
  • 24.La Rosa SL, Leth ML, Michalak L, Hansen ME, Pudlo NA, Glowacki R, et al. The human gut Firmicute Roseburia intestinalis is a primary degrader of dietary beta-mannans. Nat Commun. 2019;10: 905. doi: 10.1038/s41467-019-08812-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lindstadt LJ, Lo G, Leivers S, Lu Z, Michalak L, Pereira GV, et al. Human gut Faecalibacterium prausnitzii deploys a highly efficient conserved system to cross-feed on β-mannan-derived oligosaccharides. mBio. 2021;12(3):e0362820. doi: 10.1128/mBio.03628-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Terrapon N, Lombard V, Drula É, Lapébie P, Al-Masaudi S, Gilbert HJ, et al. PULDB: the expanded database of Polysaccharide Utilization Loci. Nucleic Acids Res. 2018;46(D1): D677–D683. doi: 10.1093/nar/gkx1022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Li W, Godzik A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics. 2006;22(13): 1658–1659. doi: 10.1093/bioinformatics/btl158 [DOI] [PubMed] [Google Scholar]
  • 28.Katoh K, Rozewicki J, Yamada KD. MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization. Brief Bioinform. 2019;20(4): 1160–1166. doi: 10.1093/bib/bbx108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Capella-Gutierrez S, Silla-Martinez JM, Gabaldon T. trimAl: a tool for automated alignment trimming. Bioinformatics. 2009;25(15): 1972–1973. doi: 10.1093/bioinformatics/btp348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol. 2003;52: 696–704. doi: 10.1080/10635150390235520 [DOI] [PubMed] [Google Scholar]
  • 31.Lefort V, Desper R, Gascuel 0. FastME 2.0: A comprehensive, accurate, and fast distance-based phylogeny inference program. Mol Biol Evol. 2015;32: 2798–2800. doi: 10.1093/molbev/msv150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Käll L, Krogh A, Sonnhammer EL. A combined transmembrane topology and signal peptide prediction method. J Mol Biol. 2004;338: 1027–1036. doi: 10.1016/j.jmb.2004.03.016 [DOI] [PubMed] [Google Scholar]
  • 33.Helbert W, Poulet L, Drouillard S, Mathieu S, Loiodice M, Couturier M, et al. Discovery of novel carbohydrate-active enzymes through the rational exploration of the protein sequences space. Proc Nat Acad Sci U S A. 2019;116:v6063–6068. doi: 10.1073/pnas.1815791116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kidby DK, Davidson DJ. A convenient ferricyanide estimation of reducing sugars in the nanomole range. Anal Biochem. 1973;55:321–325. doi: 10.1016/0003-2697(73)90323-0 [DOI] [PubMed] [Google Scholar]
  • 35.Mathieu S, Henrissat B, Labre F, Skjåk-Bræk G, Helbert W. Functional exploration of the polysaccharide lyase family PL6. PLoS One. 2016;11(7):e0159415. doi: 10.1371/journal.pone.0159415 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Israel Silman

7 Mar 2022

PONE-D-22-02049Functional exploration of the Glycoside Hydrolase family GH113PLOS ONE

Dear Dr. Couturier,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In your revised manuscript please pay particular attention to the constructive comments of Reviewer 1.

Please submit your revised manuscript by Apr 21 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Israel Silman

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

[This work was financially supported by the Institut Carnot PolyNat (ANR-17-CARN-0025-0). M.C., W.H., C.C. have received support from the Glyco@Alps Cross-Disciplinary Program (Grant ANR-15-IDEX-02), Labex ARCANE, and Grenoble Graduate School in Chemistry, Biology, and Health (Grant ANR-17-EURE-0003). Sophie Mathieu and Laurent Poulet are thanked for their help with plasmid transformation.]

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

 [The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.]

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Couturier et al have mapped the function of GH113 in representative parts of the phylogenetic tree. This is a much needed study on an underexplored family of carbohydrate active enzymes so far seen to contain beta-mannanases. The work is very comprehensive and of fine quality. Some points to be considered are listed below.

1. One obvious shortcoming of the functional characterization of the enzymes by describing the oligosaccharide product profiles is that the substrates used can contain galactose and glucose in addition to mannose. Can the precise structures of the various oligosaccharide products be informed?

2. In the abstract please inform that a fifth clade has not been functionally characterized.

3. Please mention that GH113 belongs to GH clan A

4. CBM8 is described in CAZy as a cellulose binding module. Can the authors inform more on the single GH113 exception that carries this CBM? (line 87)

5. It would be helpful for readers to show a figure with structures of the different substrates, which would be particularly relevant in connection with the results in Tables 1 and 2. This point of concern relates to the point #1 above. Note that konjac glucomannan contains glucose which might be reasonable to indicate in Table 2.

6. The author’s state that the activity assayed on the different oligo- and polysaccharide substrates was determined using “suitably diluted enzyme” solutions. The enzyme concentration is important to informed (for example as a range given the relevant section in Methods). In particular for cases where no activity was determined the used enzyme concentrations are particularly important to inform. Ideally the enzyme concentration in such cases should be up to 3-4 orders of magnitude higher than the concentrations used for enzymes where activity was measurable.

7. Please describe how the ivory nut mannan was solubilized as well as how the oligosaccharides thereof were prepared.

8. Please describe which mannan is used in Figure 2.

9. If structure determined GH113’s are part of the presentations perhaps indicate which are these (Figures S1, S2, more?).

10. The four chromatograms in Figure S2, what do they present? Which enzyme is used? (EDP22100, is hard to identify)

11. Are glucotrioses A and B defined?

12. Why are clades 3 and 4 not represented in Table 2?

13. The text lines 243-248 is not easy to understand

14. The GTs mentioned in line 50, would they have been identified – or is the produced polysaccharide identified - in a way that allows speculation on the specificity of Clade 5 to a level suggesting specificity with regard to carbohydrate contents in substrates?

15. Can purity and yields of recombinant enzymes be informed as SI?

Minor:

1. Replace tridimensional with three-dimensional

2. Make sure all references adopt consistently to the required style with regard to titles being in Sentence style (not Title Style), all information included, and Latin names in italics

3. Use “period sign”, not “comma” to indicate the decimal place

4. When listing the characterized enzymes (page 3) please apply italics only to the part of the name that the convention requires

5. Line 76, please after the two named species add “…enzymes.”

6. Please don’t start a sentence with a number, but spell the number out (and the unit if relevant) in such cases

7. Present abbreviations in alphabetical order

8. Consider in Methods to use “min” instead of “minutes” and “h” or “hrs” instead of “hours”. Use italics for “g” for gravity.

9. Line 218, should “where” actually be “were”?

Reviewer #2: I enjoyed reading this functional exploration of a poorly understood GH family. It was clearly written, the reasons for doing the experiment were clearly stated, experiments well designed and executed.

I was a bit surprised to see the high selectivity for mannan substrates and tthe mix of apparent endo and exo type reactions in the same family, but thats what discovery research is all about.

Reviewer #3: This is a very interesting and significant manuscript on the characterization of an under-explored family of glycoside hydrolases that hydrolyze mannan, a beta-mannose polymer of high industrial interest, especially in terms of biomass valorization. The authors were able to unveil the functional diversity of enzymes of this GH family by classifying the product profile (mannanase and mannosidase activities) of a set of 31 enzymes on the basis of protein sequence diversity. The manuscript is very well written and the results are sound and they increase our understanding of GH113 enzyme sand beta-mannanases in general. It is a very well performed multidisciplinary work, combining bioinformatics with biochemistry and chemical biology techniques, which in my opinion deserves publication in Plos One.

- The acronyms DP2, DP3 and DP4 (page2 ) should be defined.

- It is worth citing ACS Cent. Sci 2016, 2, 896 for the structural characterization of the lysozyme-like fold of GH134 beta-mannanase and catalytic mechanism

- May be the authors could define the difference between mannanases and mannosidases, which I think is not obvious to the general reader

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Apr 22;17(4):e0267509. doi: 10.1371/journal.pone.0267509.r002

Author response to Decision Letter 0


1 Apr 2022

The authors thank the reviewers for their careful reading of our manuscript and their kind and stimulating words. We have carefully taken into account all their comments and recommendations. Please find below our point to point answers.

Reviewer #1: Couturier et al have mapped the function of GH113 in representative parts of the phylogenetic tree. This is a much needed study on an underexplored family of carbohydrate active enzymes so far seen to contain beta-mannanases. The work is very comprehensive and of fine quality. Some points to be considered are listed below.

1. One obvious shortcoming of the functional characterization of the enzymes by describing the oligosaccharide product profiles is that the substrates used can contain galactose and glucose in addition to mannose. Can the precise structures of the various oligosaccharide products be informed?

The collection of substrates, including branched mannans, was used for the screening experiments. The end-products and, therefore, the specificity of the enzymes were determined using only linear mannans, either polysaccharide (unbranched beta 1,4 linear mannan from carob), or oligosaccharides (unbranched beta 1,4 linear mannan from carob digested with an endo-enzyme). Therefore, the structures of the produced oligo-saccharides were unambiguously linear and only composed of mannose. Size exclusion chromatography analyses with appropriate oligo-mannans standards allowed us to determine the DP of the released products. The end-products obtained after digestion of branched mannan (e.g. galactomannan) and glucomannan were not investigated.

To clarify this, we have modified Table 1 sothat major end products clearly relate with the corresponding substrate.

2. In the abstract please inform that a fifth clade has not been functionally characterized.

We modified the sentence l.23: “We were able to assign mannanase and mannosidase activities to four out of the five clades of the family.”

3. Please mention that GH113 belongs to GH clan A

The following sentences are mentioned in the manuscript l.59-64 : “Contrasting with family GH134, the other families of mannan-degrading enzymes belong to same structural clan GH-A. Accordingly, mannanases from families GH5, GH26 and GH113 share remote homology, notably testified by the same (β/α)8 barrel tri-dimensional structure, the same catalytic amino acids (Glu/Glu, catalytic nucleophile/catalytic proton donor) and the same catalytic mechanism leading to the retention of the anomeric configuration.” However, we re-emphasized it l.79 “The crystal structures of three GH113 enzymes have been solved, confirming their belonging to clan GH-A”.

4. CBM8 is described in CAZy as a cellulose binding module. Can the authors inform more on the single GH113 exception that carries this CBM? (line 87)

The CBM8-GH113 mentioned in the manuscript is from the marine organism Ardenticatena sp. The only CBM8 characterized to date exhibits binding to cellulose, but its sequence has only 36% identity with that of Ardenticatena. Among other CBM8, many are attached to GH18 enzymes (mostly chitinases), and some are attached to GH5_40 (putative mannanases) which suggests that the substrates targeted by CBM8 could be more diverse than just cellulose. Hence, not much information can be extrapolated from this CBM8 in terms of substrate prediction. We modified the text l. 88 as follows: “Analysis of the GH113 containing proteins revealed that the vast majority are composed of this sole domain, with a single exception in the marine bacteria Ardenticatena sp. whose GH113 bears a Carbohydrate Binding Module (CBM) from family CBM8. Binding to cellulose has been demonstrated for one CBM8 which shares only 36% identity with the CBM8 from Ardenticatena sp. Many other CBM8 sequences are found attached to a variety of enzymes, including GH18 enzymes which are mostly chitinases, or, interestingly, putative mannanases from GH5_40 subfamily.

5. It would be helpful for readers to show a figure with structures of the different substrates, which would be particularly relevant in connection with the results in Tables 1 and 2. This point of concern relates to the point #1 above. Note that konjac glucomannan contains glucose which might be reasonable to indicate in Table 2.

We are aware that the structural diversity of mannan substrates used in the study might be a source of confusion among the readers who are not familiar with this group of polysaccharides. As suggested by the reviewer, we added a supplementary figure S2 which provides an overview of the composition and structure on the three types of mannans used in our study.

6. The author’s state that the activity assayed on the different oligo- and polysaccharide substrates was determined using “suitably diluted enzyme” solutions. The enzyme concentration is important to informed (for example as a range given the relevant section in Methods). In particular for cases where no activity was determined the used enzyme concentrations are particularly important to inform. Ideally the enzyme concentration in such cases should be up to 3-4 orders of magnitude higher than the concentrations used for enzymes where activity was measurable.

We acknowledge the importance of this information and we added the range of µg of enzyme used per assay in the text (l.320).

7. Please describe how the ivory nut mannan was solubilized as well as how the oligosaccharides thereof were prepared.

The ivory nut mannan as well as beta 1,4 linear mannan from carob are insoluble in water and were actually prepared as suspensions and not as solutions. This was explicated in the materials and methods section (l.318) as follows: “Substrates were prepared as 0.4% solutions or suspensions in the case of insoluble substrates (e.g. ivory nut mannan, carob mannan)”. We have also indicated in Table S2 which mannans are insoluble. The oligosaccharides were prepared as described in the materials and methods section, l. 328.

8. Please describe which mannan is used in Figure 2.

We used debranched linear beta 1,4 mannan from carob in figure 2 and this was added in the section title (l.153), in the text (l.157) and in the figure legend (l. 172).

9. If structure determined GH113’s are part of the presentations perhaps indicate which are these (Figures S1, S2, more?).

This request from the reviewer was not clear to us. We propose to indicate in Table 1 which GH113 enzyme three dimensional structures have been solved in previous studies.

10. The four chromatograms in Figure S2, what do they present? Which enzyme is used? (EDP22100, is hard to identify)

Figure S2 shows the degradation products of linear manno-oligosaccharides digested with one of the exo-mannosidases from clade 1 and analyzed by size exclusion chromatography. Because the mannose (M1) is not clearly separated from the salt peak using this method, we then switched to HPAEC analysis which is presented in Figure 3. We modified the title to make it more explicit as to which enzyme and substrates were used: “Degradation of linear mannooligosaccharides by a clade 1 GH113 exo-mannosidase representative”.

11. Are glucotrioses A and B defined?

Thanks for pointing that out. We renamed the two glucotrioses with more informative names, respectively Glucosyl-(1→3)-β-D-Cellobiose and Cellobiosyl-(1→3)-β-D-Glucose in the supplementary Table S1. We also renamed the “Glucotetraose B” to the more informative name: “Cellotriosyl-(1→3)-β-D-Glucose”.

12. Why are clades 3 and 4 not represented in Table 2?

In this table we wanted to compare the specific activities of endo-enzymes with different end product patterns. Therefore, we chose enzymes not according to the clade they were located in but rather differentiating M1+M2 vs M3+M4 producing enzymes. Clades 2, 3 and 4 all gathers M3+M4 producing enzymes therefore only one was used. The title (l.196) was modified as follows: “Specific activity of representatives of M1+ M2 producing enzymes (Clade 1 (AJZ27962.1, Clade 1) and M3+M4 producing enzymes (CCO05952.1, Clade 2) towards mannans.”

13. The text lines 243-248 is not easy to understand

We rephrased this section (now l.256-261) by splitting it as follows: “In the case of the Bacteroidetes GH113 (Clade 5) there is a small number of genes predicted in a PUL compared to the size of the family (26/661, 4%). Moreover, these PULs contain none or a single additional degradative CAZyme (only three Cyclobacterium species having two GH144-encoding genes, usually involved in β-1,2 glucan breakdown). This suggests that these enzymes are unlikely to participate in a complex polysaccharide uptake.”

14. The GTs mentioned in line 50, would they have been identified – or is the produced polysaccharide identified - in a way that allows speculation on the specificity of Clade 5 to a level suggesting specificity with regard to carbohydrate contents in substrates?

The GT found with GH113 on PUL are classified in the large GT2 families, which gathers more than 280000 sequences, with very different substrates specificities. We observed that in many of these GH113-containing PULs there are three GT2: one with little identity to characterized GT2, and two others with some similarity to GT2 mannosyltransferases. We added a sentence in the manuscript, l.264. “Accordingly, we observed that among the large diversity of specificities in family GT2, some of the GT2 located in GH113-containing PULs exhibit similarity with mannosyltransferases.”

15. Can purity and yields of recombinant enzymes be informed as SI?

After purification, the purity of enzymes was attested by a single band visible on SDS-PAGE and estimated to be >90%. The molecular weights were ranging from 35 kDa to 47 kDa, as expected. Final protein concentrations were comprised between approximatively 2 and 6 mg.mL-1, for 50 ml of culture volume. We added these informations in the manuscript, l.134.

Minor:

1. Replace tridimensional with three-dimensional

We have checked and corrected it throughout the manuscript.

2. Make sure all references adopt consistently to the required style with regard to titles being in Sentence style (not Title Style), all information included, and Latin names in italics

We double-checked and edited accordingly the reference list.

3. Use “period sign”, not “comma” to indicate the decimal place

Checked and corrected.

4. When listing the characterized enzymes (page 3) please apply italics only to the part of the name that the convention requires

Corrected page 3 and in the Table 1.

5. Line 76, please after the two named species add “…enzymes.”

Corrected.

6. Please don’t start a sentence with a number, but spell the number out (and the unit if relevant) in such cases.

We have corrected it throughout the manuscript.

7. Present abbreviations in alphabetical order

We have corrected the abbreviation list to alphabetical order.

8. Consider in Methods to use “min” instead of “minutes” and “h” or “hrs” instead of “hours”. Use italics for “g” for gravity.

Corrected.

9. Line 218, should “where” actually be “were”?

Yes, thank you. Corrected.

Reviewer #2: I enjoyed reading this functional exploration of a poorly understood GH family. It was clearly written, the reasons for doing the experiment were clearly stated, experiments well designed and executed.

I was a bit surprised to see the high selectivity for mannan substrates and tthe mix of apparent endo and exo type reactions in the same family, but thats what discovery research is all about.

We thank the reviewer for the nice comments on our manuscript. It is actually interesting that the GH113 family seems to exhibit very strong specificity for mannans, given that most CAZy families are polyspecific, such as the large and well-studied families GH5 and GH43. However, other families have also been shown to gather enzymes that act on a single family of substrate, such as GH14 (alpha-amylases) or GH134 (beta-mannanases). In the case of family GH11, similar as to what we see for GH113, all characterized enzymes so far have shown activity on xylan, with some enzymes having an endo (beta-xylanases) and others an exo (beta-xylosidases) mode of action.

Reviewer #3: This is a very interesting and significant manuscript on the characterization of an under-explored family of glycoside hydrolases that hydrolyze mannan, a beta-mannose polymer of high industrial interest, especially in terms of biomass valorization. The authors were able to unveil the functional diversity of enzymes of this GH family by classifying the product profile (mannanase and mannosidase activities) of a set of 31 enzymes on the basis of protein sequence diversity. The manuscript is very well written and the results are sound and they increase our understanding of GH113 enzyme sand beta-mannanases in general. It is a very well performed multidisciplinary work, combining bioinformatics with biochemistry and chemical biology techniques, which in my opinion deserves publication in Plos One.

We thank the reviewer for the nice comments and careful reviewing of our work. Please find our answers to your questions below.

- The acronyms DP2, DP3 and DP4 (page2 ) should be defined.

Thank you for identifying this point. We corrected the sentence l.50 as follows: “As examples, a degree of polymerization of 2 to 3 (DP2/DP3)”

- It is worth citing ACS Cent. Sci 2016, 2, 896 for the structural characterization of the lysozyme-like fold of GH134 beta-mannanase and catalytic mechanism

The suggested publication was cited in the text and added to the reference list.

- May be the authors could define the difference between mannanases and mannosidases, which I think is not obvious to the general reader

We defined those terms l. 74 as follows: endo-β-mannanase activity has been identified for four of them (i.e. the enzymes cleave randomly the mannan backbone), and exo-mannosidase activity was described for R. intestinalis and F. spraunitzii enzymes (i.e. the enzymes release mannose from the extremity of manno-oligosaccharides).

Modifications to the reference list:

We identified two mistakes in the cited references: The paper by Lombard et al. in the first version of the manuscript was replaced by the newer CAZy database reference paper Drula et al. (Reference #17), and the paper by Drula et al. was replaced by the actual correct PULDB reference Terrapon et al. (Reference #26).

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Israel Silman

5 Apr 2022

PONE-D-22-02049R1Functional exploration of the Glycoside Hydrolase family GH113PLOS ONE

Dear Dr. Couturier,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

In your revised manuscript please address the few remaining comments of Reviewer 1.

Please submit your revised manuscript by May 20 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Israel Silman

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Couturier et al have very well amended the manuscript on the function of GH113 representatives in the phylogenetic tree. A few small points to be considered are listed below.

1. Consider if there is sufficient details on the material (powder, milling, particle size – if possible) and suspension in case of insoluble polysaccharide substrates

2. Page 4, line 79. Is the attack of different enzymes possible from the non-reducing or the reducing end or both?

3. Page 5, line 90, correct to “bacterium”. Note also that lines 93-94 contain a repeated text from just before

4. Page 5, line 96, perhaps write “..from the GH5_40 subfamily.”

5. Please write throughout GenBank (not Genbank)

6. Page 7, line 140, perhaps write “..final protein concentrations were between approximately 2 etc..”

7. Page 9, line 178, replace “beta” with the Greek letter “�"

8. Page 15, line 326: would you be able to give the enzyme concentration range in molar units rather than weight?

9. I wonder if it is best to have the section “Conclusion” after Materials and Methods. Perhaps if before is possible that seems more reasonable.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Apr 22;17(4):e0267509. doi: 10.1371/journal.pone.0267509.r004

Author response to Decision Letter 1


8 Apr 2022

Thank you for the reviewing of our revised manuscript. Here are the answers to the few points raised in the revisions:

Reviewer #1: Couturier et al have very well amended the manuscript on the function of GH113 representatives in the phylogenetic tree. A few small points to be considered are listed below.

1. Consider if there is sufficient details on the material (powder, milling, particle size – if possible) and suspension in case of insoluble polysaccharide substrates

Both insoluble polysaccharides used in our study are commercial ones (available from Megazyme), and all available documentation is easily accessible through their website. We do not have any other information that would be relevant to the article.

2. Page 4, line 79. Is the attack of different enzymes possible from the non-reducing or the reducing end or both?

Both R. intestinalis and F. prauznitii GH113 are reducing-end mannosidases and this was added in the manuscript, l. 76.

3. Page 5, line 90, correct to “bacterium”. Note also that lines 93-94 contain a repeated text from just before

Both points corrected, thank you.

4. Page 5, line 96, perhaps write “..from the GH5_40 subfamily.”

Corrected.

5. Please write throughout GenBank (not Genbank)

Corrected.

6. Page 7, line 140, perhaps write “..final protein concentrations were between approximately 2 etc..”

Corrected.

7. Page 9, line 178, replace “beta” with the Greek letter “�"

Corrected.

8. Page 15, line 326: would you be able to give the enzyme concentration range in molar units rather than weight?

Yes, the corresponding molar concentrations were added to the manuscript, l. 338.

9. I wonder if it is best to have the section “Conclusion” after Materials and Methods. Perhaps if before is possible that seems more reasonable.

Yes, done.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 2

Israel Silman

11 Apr 2022

Functional exploration of the Glycoside Hydrolase family GH113

PONE-D-22-02049R2

Dear Dr. Couturier,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Israel Silman

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Israel Silman

14 Apr 2022

PONE-D-22-02049R2

Functional exploration of the Glycoside Hydrolase family GH113

Dear Dr. Couturier:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Israel Silman

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. High resolution phylogenetic tree of family GH113.

    Major taxonomic groups were color-coded (tree branches and leaf labels): red for Firmicutes, blue for Alphaproteobacteria, green for Gammaproteobacteria, black for Actinobacteria and brown for Bacteroidetes.

    (PNG)

    S2 Fig. Characteristics of the mannans used in this study.

    Symbolic representation of glycans is given with blue dots: glucose, green dots: mannose, yellow dots: galactose.

    (DOCX)

    S3 Fig. Degradation of linear mannooligosaccharides by a clade 1 GH113 representative.

    The degradation of manno-oligosaccharides by EDP22100 was monitored using size-exclusion chromatography. M1: Mannose, M2: Mannobiose, M3: mannotriose, M4: mannotetraose.

    (DOCX)

    S4 Fig. Multiple alignment of selected GH113 sequences.

    Conserved amino acids are highlighted with a red background, catalytic amino acids are indicated by a grey dot. Multiple alignment was generated using the MEGA Software (Tamura et al., 2021) and the figure was edited using ESPript 3 (Robert and Gouet, 2014).

    Supplementary references

    Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol. 2021;38:3022–3027. doi: 10.1093/molbev/msab120.

    Robert X, Gouet P. Deciphering key features in protein structures with the new ENDscript server. Nucl Acids Res. 2014; 42(W1): W320-W324. doi: 10.1093/nar/gku316).

    (DOCX)

    S5 Fig. Comparison of mannanase-encoding gene repertoires in Clade 1 organisms using double hierarchical clustering.

    Top tree shows mannanase families or subfamilies, left tree highlights clusters in Clade 1 fungi defined by number of mannanase-encoding genes. Abundance of the different genes within a family is represented by a colour scale from 0 (white) to the maximal number for each family (red) per species. The figure was edited using Morpheus (https://software.broadinstitute.org/morpheus/). A hierarchical clustering was performed with the option "one minus pearson correlation " on the rows. The linkage method used was average.

    (DOCX)

    S1 Table. List of polysaccharides used in this study.

    CM: Carboxymethyl, CWP: Cell wall polysaccharides.

    (DOCX)

    S2 Table. List of synthetic substrates used in this study.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES